DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $15,239,000 | +0.4% | 59,001 | -1.5% | 2.83% | +25.1% |
| Q2 2022 | $15,181,000 | -14.3% | 59,880 | -0.9% | 2.26% | +1.6% |
| Q1 2022 | $17,719,000 | -10.8% | 60,405 | +0.1% | 2.22% | -1.0% |
| Q4 2021 | $19,863,000 | +25.9% | 60,371 | +2.7% | 2.25% | +7.7% |
| Q3 2021 | $15,781,000 | 0.0% | 58,804 | 0.0% | 2.09% | +0.2% |
| Q2 2021 | $15,781,000 | +18.3% | 58,804 | -0.8% | 2.08% | +13.4% |
| Q1 2021 | $13,345,000 | -19.3% | 59,289 | -20.4% | 1.84% | -18.6% |
| Q4 2020 | $16,546,000 | +2.1% | 74,484 | -1.1% | 2.26% | -9.3% |
| Q3 2020 | $16,213,000 | +21.2% | 75,294 | -0.4% | 2.49% | +14.0% |
| Q2 2020 | $13,374,000 | +26.3% | 75,632 | -1.1% | 2.18% | +4.9% |
| Q1 2020 | $10,586,000 | -9.6% | 76,482 | +0.3% | 2.08% | +15.9% |
| Q4 2019 | $11,704,000 | +4.9% | 76,257 | -1.3% | 1.79% | -1.6% |
| Q3 2019 | $11,155,000 | +2.9% | 77,235 | +1.8% | 1.82% | -3.2% |
| Q2 2019 | $10,845,000 | +11.8% | 75,880 | +3.3% | 1.88% | +5.0% |
| Q1 2019 | $9,701,000 | +149.5% | 73,480 | +94.9% | 1.79% | +123.7% |
| Q4 2018 | $3,888,000 | -5.4% | 37,700 | -0.3% | 0.80% | +11.5% |
| Q3 2018 | $4,111,000 | – | 37,830 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |